Literature DB >> 16187255

Endothelin-1 levels predict 3-year survival in patients who have amputation for critical leg ischaemia.

D J Newton1, F Khan, M McLaren, G Kennedy, J J F Belch.   

Abstract

BACKGROUND: Most patients with critical leg ischaemia (CLI) have co-existing coronary heart disease, which is the main cause of their increased mortality rate. The aim of this study was to investigate whether any markers of endothelial function could predict death in these patients.
METHODS: In a cohort of 39 patients with CLI who were scheduled for lower-limb amputation, blood levels of vascular endothelial growth factor, homocysteine, endothelin (ET) 1, von Willebrand factor and vascular cell adhesion molecule 1 were measured, as well as forearm vascular responses to the endothelium-dependent vasodilator acetylcholine.
RESULTS: Levels of ET-1 were significantly higher in patients who subsequently died within 3 years than in those who were still alive (P = 0.002) and Cox proportional hazards regression analysis demonstrated that ET-1 was an independent predictor of all-cause mortality:hazard ratio 3.53 (95 per cent confidence interval (c.i.) 1.29 to 9.70; P = 0.007) and cardiovascular mortality:hazard ratio 4.15 (95 per cent c.i. 1.30 to 13.23); P = 0.014.
CONCLUSION: ET-1 was an independent predictor of death in these patients with CLI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187255     DOI: 10.1002/bjs.5144

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia.

Authors:  Michael Richard Dashwood; Janice C S Tsui
Journal:  J Cell Commun Signal       Date:  2010-11-27       Impact factor: 5.782

2.  Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease.

Authors:  Dustin Neff; Alisha M Kuhlenhoelter; Chen Lin; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-22       Impact factor: 3.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.